Modulator of apoptosis 1 (MOAP-1) is a BH3-like
protein that plays key roles in cell death or apoptosis. It is an integral partner to the
tumor suppressor protein, Ras association domain family 1A (RASSF1A), and functions to activate the Bcl-2 family
pro-apoptotic protein Bax. Although RASSF1A is now considered a bona fide
tumor suppressor protein, the role of MOAP-1 as a
tumor suppressor protein has yet to be determined. In this study, we present several lines of evidence from
cancer databases, immunoblotting of
cancer cells, proliferation, and xenograft assays as well as
DNA microarray analysis to demonstrate the role of MOAP-1 as a
tumor suppressor protein. Frequent loss of MOAP-1 expression, in at least some
cancers, appears to be attributed to
mRNA down-regulation and the rapid proteasomal degradation of MOAP-1 that could be reversed utilizing the
proteasome inhibitor MG132. Overexpression of MOAP-1 in several
cancer cell lines resulted in reduced
tumorigenesis and up-regulation of genes involved in
cancer regulatory pathways that include apoptosis (p53, Fas, and MST1), DNA damage control (
poly(ADP)-ribose polymerase and
ataxia telangiectasia mutated), those within the cell metabolism (IR-α, IR-β, and
AMP-activated protein kinase), and a stabilizing effect on microtubules. The loss of RASSF1A (an upstream regulator of MOAP-1) is one of the earliest detectable epigenetically silenced
tumor suppressor proteins in
cancer, and we speculate that the additional loss of function of MOAP-1 may be a second hit to functionally compromise the RASSF1A/MOAP-1
death receptor-dependent pathway and drive
tumorigenesis.